Kidney Research and Clinical Practice10.23876/j.krcp.20.2202021403411-418Hyperuricemia is a risk factor for the progression to end-stage renal disease in minimal change diseaseSu Hyun Song, Tae Ryom Oh, Hong Sang Choi, Chang Seong Kim, Dong Ryeol Ryu, Sung Gyun Kim, Sun-Hee Park, Seong Kwon Ma, Soo Wan Kim, Eun Hui Bae,,,
Pediatrics & Neonatology10.1016/j.pedneo.2015.05.0052016574263-264Albuminuria in Childhood is a Risk Factor for Chronic Kidney Disease and End-Stage Renal DiseaseChi-Hui Cheng,
Journal of Renal Care10.1111/j.1755-6686.2007.tb00053.x2007333105-107HOW TO PREVENT PROGRESSION TO END STAGE RENAL DISEASEMarkus Riegersperger, Gere Sunder-Plassmann,
Psychosocial Care of End-Stage Organ Disease and Transplant Patients10.1007/978-3-319-94914-7_5201863-71Chronic and End-Stage Renal Disease and Indications for Renal TransplantationAdetokunbo Taiwo
Kidney International10.1038/ki.2014.262015871242Corrections to "Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease",
Diabetic Medicine10.1002/(sici)1096-9136(1998120);2-y199815S4S51-S56Preventing end-stage renal diseaseCarl Erik Mogensen,;2-Y/fullpdf
Science-Business eXchange10.1038/scibx.2013.2762013611276-276Carbamylated serum albumin as a risk factor for mortality in end-stage renal disease (ESRD),,
Nephrology10.1046/j.1440-1797.8.s.8.x20038S40-S44C-reactive protein as a cardiovascular risk factor and its therapeutic implications in end-stage renal disease patientsJung Sik PARK, Soon Bae KIM,,
Transplantation Proceedings10.1016/s0041-1345(98)02040-51999311-21393-1394Focal segmental glomerulosclerosis progression to end-stage renal disease within 48 months is a risk factor for recurrence after pediatric renal transplantationS.J Kim, M Kim, J Ha, I.M Jung, T.S Lee, H.I Cheong, Y Choi, H.S Lee,
Mayo Clinic Proceedings10.1016/j.mayocp.2017.12.0182018932133-135Disease Progression and End-Stage Renal Disease in Diverse GlomerulopathiesKarl A. Nath, Fernando C. Fervenza,